Mercator Medical S.A. (MRC.WA)
PLN 43.1
(1.41%)
PLN 43.1
(1.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -87.11 Million PLN | -18.68% |
| 2022 | -73.4 Million PLN | -115.84% |
| 2021 | 463.43 Million PLN | -55.76% |
| 2020 | 1.04 Billion PLN | 10223.42% |
| 2019 | 10.14 Million PLN | -38.17% |
| 2018 | 16.41 Million PLN | 92.04% |
| 2017 | 8.54 Million PLN | -53.12% |
| 2016 | 18.23 Million PLN | 10.53% |
| 2015 | 16.49 Million PLN | 25.79% |
| 2014 | 13.11 Million PLN | 13.46% |
| 2013 | 11.55 Million PLN | 35.22% |
| 2012 | 8.54 Million PLN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.91 Million PLN | 62.05% |
| 2024 Q2 | -4.92 Million PLN | 50.31% |
| 2023 Q3 | -7.04 Million PLN | 66.32% |
| 2023 Q2 | -20.92 Million PLN | -1.33% |
| 2023 FY | -87.11 Million PLN | -18.68% |
| 2023 Q4 | -26.13 Million PLN | -270.8% |
| 2023 Q1 | -20.64 Million PLN | 39.67% |
| 2022 Q2 | -3.03 Million PLN | -126.39% |
| 2022 Q3 | 19.96 Million PLN | 758.79% |
| 2022 Q4 | -34.22 Million PLN | -271.42% |
| 2022 FY | -73.4 Million PLN | -115.84% |
| 2022 Q1 | 11.48 Million PLN | 3804.52% |
| 2021 Q2 | 113.71 Million PLN | -61.7% |
| 2021 Q1 | 296.9 Million PLN | -25.88% |
| 2021 Q4 | -310 Thousand PLN | -100.58% |
| 2021 FY | 463.43 Million PLN | -55.76% |
| 2021 Q3 | 53.12 Million PLN | -53.28% |
| 2020 FY | 1.04 Billion PLN | 10223.42% |
| 2020 Q2 | 229.99 Million PLN | 647.57% |
| 2020 Q3 | 386.29 Million PLN | 67.96% |
| 2020 Q4 | 400.56 Million PLN | 3.69% |
| 2020 Q1 | 30.76 Million PLN | 926.53% |
| 2019 Q3 | 4.46 Million PLN | 96.7% |
| 2019 FY | 10.14 Million PLN | -38.17% |
| 2019 Q2 | 2.27 Million PLN | 189.27% |
| 2019 Q4 | 2.99 Million PLN | -32.94% |
| 2019 Q1 | -2.54 Million PLN | -174.68% |
| 2018 Q2 | 4.69 Million PLN | -1.53% |
| 2018 FY | 16.41 Million PLN | 92.04% |
| 2018 Q3 | 3.53 Million PLN | -24.71% |
| 2018 Q4 | 3.4 Million PLN | -3.65% |
| 2018 Q1 | 4.77 Million PLN | 34.66% |
| 2017 FY | 8.54 Million PLN | -53.12% |
| 2017 Q1 | 1.72 Million PLN | -57.38% |
| 2017 Q2 | 728 Thousand PLN | -57.7% |
| 2017 Q3 | 1.82 Million PLN | 150.27% |
| 2017 Q4 | 3.54 Million PLN | 94.46% |
| 2016 Q2 | 4.49 Million PLN | 5.09% |
| 2016 Q3 | 5.41 Million PLN | 20.36% |
| 2016 Q4 | 4.03 Million PLN | -25.42% |
| 2016 Q1 | 4.28 Million PLN | 7.51% |
| 2016 FY | 18.23 Million PLN | 10.53% |
| 2015 Q3 | 5 Million PLN | 28.27% |
| 2015 FY | 16.49 Million PLN | 25.79% |
| 2015 Q2 | 3.9 Million PLN | 8.15% |
| 2015 Q1 | 3.6 Million PLN | 11.43% |
| 2015 Q4 | 3.98 Million PLN | -20.44% |
| 2014 Q4 | 3.23 Million PLN | -22.63% |
| 2014 FY | 13.11 Million PLN | 13.46% |
| 2014 Q1 | 2.38 Million PLN | 5.4% |
| 2014 Q2 | 3.31 Million PLN | 39.02% |
| 2014 Q3 | 4.18 Million PLN | 26.4% |
| 2013 Q2 | 2.87 Million PLN | -1.74% |
| 2013 Q4 | 2.25 Million PLN | -36.37% |
| 2013 FY | 11.55 Million PLN | 35.22% |
| 2013 Q1 | 2.92 Million PLN | 33.12% |
| 2013 Q3 | 3.55 Million PLN | 23.56% |
| 2012 FY | 8.54 Million PLN | 0.0% |
| 2012 Q3 | 2.19 Million PLN | 0.0% |
| 2012 Q4 | 2.19 Million PLN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Airway Medix S.A. | -2.48 Million PLN | -3400.0% |